PD
CAPR icon

Point72 (DIFC)’s Capricor Therapeutics CAPR Stock Holding History

Point72 (DIFC)’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3.72K Buy
+516
New +$3.8K ﹤0.01% 1024

Other funds holding CAPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Point72 (DIFC)'s CAPR Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Capricor Therapeutics (CAPR) in Q3 2025: 516 shares worth $3.72K. The stake represents ﹤0.01% of the portfolio and ranks #1024 among its holdings.

115 funds tracked by Wall St. Rank hold CAPR as of Q3 2025.

  • Point72 (DIFC) held 516 shares of Capricor Therapeutics worth $3.72K as of Q3 2025.
  • Capricor Therapeutics was a new Point72 (DIFC) position in Q3 2025.
  • Capricor Therapeutics made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #1024 holding.
  • 115 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.